---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-005397"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2023-01-20T23:59:59+00:00"
generated_at: "2026-06-20T12:35:52.974109+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA Pharma receives Nasdaq non-compliance notice for bid price below $1.00

## Summary
- Nasdaq letter on Jan 17, 2023: bid price below $1.00 for 30 consecutive business days.
- 180-day cure period until July 17, 2023 to regain compliance by closing at $1.00 for 10 days.
- Company evaluating options including reverse stock split authorized at June 2022 meeting.

## SEC filing metadata
- accession: 0001104659-23-005397
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2023-01-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465923005397/0001104659-23-005397-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465923005397/tm234019d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-005397
- JSON: https://secwatch.observer/filing/0001104659-23-005397.json
- Plain text: https://secwatch.observer/filing/0001104659-23-005397.txt

## Key facts
- Listing & Compliance Notices
  HOOKIPA Pharma Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: January 17, 2023, HOOKIPA Pharma Inc. (the “Company”) received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the closing bid price of the Company’s common stock was below $1.00 per share for 30 consecutive business days, and that, therefore, the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), which is the minimum bid price requirement for continued listing on the Nasdaq Global Select Market. The notice from Nasdaq has no immediate effect on the listing of the Company’s common stock, and the common stock will continue to be listed on the Nasdaq Global Se
  evidence_url: https://www.sec.gov/Archives/edgar/data/1760542/000110465923005397/0001104659-23-005397-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.